Disease | pneumonia |
Phenotype | C0948265|metabolic syndrome |
Sentences | 1 |
PubMedID- 21109917 | Objective: to evaluate the inflammatory markers interleukin-6 (il-6) and tumor necrosis factor-alpha (tnf-alpha), as well as anti-chlamydia pneumoniae antibodies, in patients with metabolic syndrome (ms), with and without cardiovascular events. |
Page: 1